Andrew A. Hindman, Chief Business Officer at ACORDA THERAPEUTICS INC (ACOR), sold 85,230 shares at $24.26 ($2.1M) on 2018-05-25, disclosed to the SEC on 2018-05-30.
Seasonal sale ($2.1M) by Chief Business Officer — this insider has traded ACOR in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.26 | 42,615 | $1.0M | 50.0% |
| 2 | $24.26 | 42,615 | $1.0M | 50.0% |
| Total | $24.26 avg | 85,230 | $2.1M | 100% |
| Filing → |
| ACOR | SELL | 2017-12-05 | $17K | — | Filing → |
| ACOR | SELL | 2017-05-17 | $121K | — | Filing → |
| ACOR | SELL | 2016-12-05 | $9K | — | Filing → |